# Medical Technology Venture Partners

Medical Technology Venture Partners is a Venture Capital based in Menlo Park, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Menlo Park, United States
- **Region:** North America
- **Address:** Menlo Park, CA, United States
- **Founded:** 2017
- **Assets under management:** Undisclosed
- **Website:** www.medtechvp.com
- **LinkedIn:** https://www.linkedin.com/company/mtvp

## Regulatory record

- **Reports private funds:** No

## About

MedTech Venture Partners funds and supports medical technology entrepreneurs. Combined, the team has overseen the conception, development, and launch of over 30 medical devices and diagnostics products, with experience scaling early-stage device businesses and clinical and regulatory work globally. Together with partners at UCSF they are building an ecosystem around early stage medical devices.

## Sectors

- Medical Devices
- Diagnostics
- Digital Health
- MedTech

## People

- Thomas Glanzmann — Partner
- Radu Cautis — Partner & Managing Director
- Peter Loescher — Partner
- Javad Seyedzadeh — Partner
- Regis Kelly — Venture Partner
- Christine Winoto — Venture Partner
- Mathew Likens — EIR & Venture Partner

## Questions

### Who runs investment decisions at Medical Technology Venture Partners?

Radu Cautis serves as Partner & Managing Director and leads the investment process. He built his operating career at Gambro, scaling its Asia device business and leading strategic marketing, before moving into venture. He is supported by a partnership of former CEOs, including Thomas Glanzmann (ex-Gambro) and Peter Loescher (ex-Siemens), who engage directly with portfolio companies on clinical and regulatory strategy.

### How does the firm source proprietary deal flow?

Sourcing runs through the personal clinical networks of its operating partners and venture partners. Christine Winoto and Regis Kelly bring direct access to the UCSF medtech pipeline through their leadership of the Rosenman Institute and QB3 program. The firm does not advertise standard associate-led sourcing or a broad GP conference circuit; instead, its partners identify device entrepreneurs during clinical-fellow rotations and academic prototyping labs.

### Does the firm participate in fund commitments or only direct deals?

The portfolio page lists only direct company investments. There is no public record of Medical Technology Venture Partners making LP commitments into external venture funds. Its model is built on taking board-level, operator-intensive positions in individual medtech startups.

### Which sectors does the firm explicitly avoid?

The firm's exclusive focus on medical devices and diagnostics means it does not invest in biopharma therapeutics, healthcare services, or pure health IT plays. Its portfolio of neuromodulation implants, surgical tools, and radiation oncology hardware reflects a specific avoidance of drug-development binary risk and a preference for 510(k)/PMA regulatory pathways.

### How does the firm handle regulatory risk in its portfolio companies?

Javad Seyedzadeh brings 30 years of quality assurance and regulatory affairs experience from Gambro, Toshiba, Bayer, and Siemens directly into the investment process. His presence means regulatory pathway feasibility is evaluated during diligence rather than outsourced to consultants, which is atypical for an early-stage venture firm.

### What are the firm's known exits?

Three exits are listed publicly. Ulthera, an aesthetic ultrasound company led by current EIR Mathew Likens, was acquired by Merz Pharma for $600 million in 2014. An umbilical catheter protection device was sold to Laborie, and an arthroscopic tissue removal tool was acquired by Zimmer. The firm does not disclose return multiples.

## Related profiles

- [Medical Properties Trust](https://altss.com/profile/medical-properties-trust-inc)
- [MEDICE](https://altss.com/profile/medice)

---

Last updated: 2026-08-11T15:07:26.757Z

Canonical page: https://altss.com/profile/medical-technology-venture-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology